Recent developments with Iovance Biotherapeutics Inc (IOVA) have led to the company’s beta value being reach 0.62 cents.
A new trading day began on Monday, with Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock price down -2.29% from the previous day of trading, before settling